A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan
ConclusionsPPI prescription is often continued in HD patients. De-prescription is not a common practice in Japan. It remains unclear whether discontinuation of PPIs should be recommended in hemodialysis patients who have a high risk of gastrointestinal ulcer. Yet, considering the side effects and polypharmacy in the HD population, more discussions on preferable de-prescription of PPIs are needed.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Acid Reflux | Dialysis | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Hemodialysis | Insurance | Japan Health | Peptic Ulcer | Proton Pump Inhibitors PPIs | Urology & Nephrology